Perspective Therapeutics Shares Rise 8.5% After Investment From Lantheus
Perspective Therapeutics Gets Equity Investment, Strategic Agreements With Lantheus
Lantheus Expects 2023 Revenue to Surpass Guidance
20 midcap stocks with 2024 upside ranging up to 62%, according to analysts
20 midcap stocks with 2024 upside ranging up to 62%, according to analysts
DexCom Stock Earns Healthy Relative Strength Rating Upgrade
Lantheus Holdings 3Q EPS $1.88 >LNTH
Boston Scientific Stock Sees IBD RS Rating Improve To 74
Why Eli Lilly's $1.4 Billion Takeover Is A Boon For More Than Just Point Biopharma
Lantheus Subsidiary to Stop Production, Promotion of Azedra
Lantheus Holdings 2Q EPS $1.33 >LNTH
Edwards Lifesciences Stock Shows Improved Relative Price Strength
Neogen Stock Shows Market Leadership With Jump To 86 RS Rating
Dow Jones Reverses As Fed's Powell Hints 5.25% Rate Soon; Tesla, Amazon Move On Analyst Ratings
Dow Jones Futures Await Fed Chief Powell; Market Rally Resists Pullback As Tesla, Nvidia Run
Health Care Down as Kenvue Rallies on Debut -- Health Care Roundup
Stock Market Limps Near Lows Ahead Of Apple Earnings; Shopify Stock Gains Over 23%
Dow Jones Tumbles As Regional Banks Crumble Ahead Of Apple Report; These Cruise Ship Operators Forecast Big Profits
Dow Jones Futures Fall As PacWest Dives On Sale Report; Apple Earnings On Tap
Lantheus Holdings 1Q Loss/Shr 4c >LNTH
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.